DGAP-News: Balda AG: Stevanato Group takes over operating business

DGAP-News: Balda AG / Key word(s): Disposal

Balda AG: Stevanato Group takes over operating business

10.03.2016 / 13:30

The issuer is solely responsible for the content of this announcement.


Bad Oeynhausen, 10 March 2016 – After Balda AG had accepted the bid by

Italian Stevanato Group on 4 February 2016 today the closing and transfer

of ownership was carried out. Consequently, all operating units of the

Balda Group and further assets have been transferred to the

Stevanato Group. The operating business will continue to operate under the

Balda name. Stevanato had handed in their binding offer in the amount of

EUR 95 million on 29 January 2016 at the extraordinary general meeting and

with it was able to win through the bidding war.

“Balda is considered an acclaimed plastics specialist, specifically in the

area of medical technology, and possesses state-of-the-art production

sites. We are very happy about our new Stevanato Group subsidiary and are

envisioning outstanding growth potential – primarily in cooperation with

our division Pharmaceutical Systems, operating under the brand Ompi”, says

Franco Stevanato, CEO of Stevanato Group.

The remaining holding will now change its name into Clere AG and will focus

entirely on the realignment of the company. No revocatory action regarding

the extraordinary general meeting has been received by the company. Thus

the change of name as well as the registration of the capital decrease is

expected to be carried out promptly.

“We are very pleased that the closing was conducted so swiftly and that the

operating units are now an integral part of the family-run Stevanato Group.

We are absolutely convinced that thereby Balda can most successfully be

developed further”, explains Oliver Oechsle, sole Management Board member

of Balda AG and adds: “Now we can completely focus our attention on the

remaining holding and dedicate ourselves to the elaboration of our new

business model under the name of Clere AG.”

Contact / Contact Person

Michael Pfister

Deekeling Arndt Advisors

Tel: +49 (0) 5734 922 2555

Mobile: +49 (0) 160 90560506

Mail: michael.pfister@deekeling-arndt.de

About Stevanato

Stevanato Group with its headquarters in Piombino Dese, Italy, was founded

in 1949 and is specialized in the production of glass containers for

pharmaceutical use, glass converting machines, visual inspection systems,

assembling and packaging machines for the pharmaceutical industry. For

instance, Stevanato Group is currently the market leader in the manufacture

of cartridges for insulin pen injectors. With more than 2400 employees

Stevanato Group generated a total of EUR 337,1 million in sales revenuesin

2015, of which 90 % are derived from export. Besides Italy, Stevanato is

present with production plants in Denmark, Slovakia, Mexico and China. One

plant is under contruction in Brazil and a sales office is present in US.


About Balda

After the sale of the operating business, the business model for the

remaining Balda will lie with investments and shareholdings in the field of

environmental and power engineering. Furthermore, the new Balda will pursue

active asset management as well as SME business participations and SME




10.03.2016 Dissemination of a Corporate News, transmitted by DGAP – a

service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English

Company: Balda AG

Bergkirchener Str. 228

32549 Bad Oeynhausen


Phone: +49 (0) 57 34 / 9 22-0

Fax: +49 (0) 57 34 / 9 22-2604

E-mail: ir@balda-group.com

Internet: www.balda-group.com

ISIN: DE0005215107

WKN: 521510

Listed: Regulated Market in Frankfurt (Prime Standard); Regulated

Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,

Munich, Stuttgart

End of News DGAP News Service


444167 10.03.2016